Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata can show unusual red-dotted vessels and dithranol treatment may mask typical patterns.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

Genetic factors might cause fibrosing alopecia linked to hair shaft abnormalities.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

A woman's nail separation was likely caused by poor blood flow, and a treatment for similar conditions might help.

Poor blood supply in hair follicles is linked to nutrient deficiency in patients with female pattern hair loss, and adding more nutrients could potentially fix this.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Trichostasis spinulosa can look like acne but usually affects adults, not children.

Women with hair loss may have higher heart disease risk.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Iron deficiency is common in kidney transplant patients, and while iron treatment helps, it can cause high red blood cell levels.

Using platelet rich fibrin speeds up wound healing after revascularization.

Plumbago zeylanica L. leaves may help dissolve blood clots and have antioxidant benefits.

Platelet-Rich Fibrin shows promise in medicine and dentistry, but more research is needed to standardize its use.

Bleomycin injections in mice cause skin thickening and hair loss.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

TCF7L2 gene polymorphism is linked to alopecia areata, but it doesn't affect the success of PRP or conventional treatments.

Multiple plasma donations do not change donors' biochemical parameters.

A new syndrome, Teelwani Syndrome, combines features of two rare genetic disorders.

Androgenetic alopecia is linked to a higher risk of varicose veins, especially in men, but not to major vascular diseases.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

The young woman has a benign, hereditary skin condition with no signs of a more serious syndrome.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

The man had pretibial myxedema and hyperthyroidism, causing skin changes and thyroid issues.

PRP treatment lacks strong evidence for routine use due to poor study quality.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.